Surmodics (SRDX)
(Real Time Quote from BATS)
$40.20 USD
+0.48 (1.21%)
Updated Aug 16, 2024 01:30 PM ET
2-Buy of 5 2
C Value B Growth A Momentum B VGM
Brokerage Reports
Surmodics, Inc. [SRDX]
Reports for Purchase
Showing records 381 - 400 ( 419 total )
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
JNJ Cordis decision to exit stent business impacts revenue/EPS; suspending PT
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Surmodics, Inc.
Industry: Medical - Products
Q2?11 SRDX reports surprising strong revenue and EPS and raises guidance
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
A FIVE STAR PATENTVEST IP VALUE COMPANY - 2011 "BEST AND BRIGHTEST" PATENTVEST REPORTS
Provider: MDB CAPITAL GROUP LLC
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Surmodics, Inc.
Industry: Medical - Products
Q1?11 a nice change of pace: revenue in-line and pro forma EPS ahead of expectations
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
Company: Surmodics, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.